Charles Rhyee
Stock Analyst
(1.92)
# 3,947
Out of 4,648 analysts
48
Total ratings
35.71%
Success rate
-5.95%
Average return
Main Sectors:
Stocks Rated by Charles Rhyee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Hold | $9 → $8 | $8.71 | -8.16% | 6 | Oct 31, 2024 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $369 → $285 | $219.05 | +30.11% | 3 | Oct 25, 2024 | |
| MEDP Medpace Holdings | Maintains: Buy | $413 → $372 | $317.33 | +17.23% | 3 | Oct 23, 2024 | |
| VEEV Veeva Systems | Maintains: Hold | $180 → $192 | $212.03 | -9.45% | 3 | Aug 29, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $27 → $23 | $16.99 | +35.37% | 2 | Aug 13, 2024 | |
| CRL Charles River Laboratories International | Maintains: Hold | $228 → $203 | $183.08 | +10.88% | 4 | Aug 12, 2024 | |
| RCM R1 RCM | Downgrades: Hold | $20 → $14 | $14.26 | +0.28% | 1 | Aug 5, 2024 | |
| GDRX GoodRx Holdings | Maintains: Buy | $14 → $16 | $6.09 | +162.68% | 7 | May 16, 2024 | |
| CAH Cardinal Health | Maintains: Market Perform | $88 → $90 | $113.35 | -20.60% | 1 | Aug 16, 2023 | |
| TALK Talkspace | Maintains: Outperform | $4 → $5 | $3.05 | +64.20% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $100 → $50 | $9.21 | +442.65% | 3 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $251 | $207.35 | +21.05% | 1 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $56 | $5.37 | +943.02% | 2 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $14 | $0.93 | +1,408.13% | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $50 | $23.98 | +108.51% | 2 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $325 → $361 | $524.67 | -31.19% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $3,240 | $1.79 | +181,412.61% | 1 | Jul 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $35 | $20.01 | +74.96% | 1 | Feb 13, 2018 |
Teladoc Health
Oct 31, 2024
Maintains: Hold
Price Target: $9 → $8
Current: $8.71
Upside: -8.16%
ICON Public Limited Company
Oct 25, 2024
Maintains: Buy
Price Target: $369 → $285
Current: $219.05
Upside: +30.11%
Medpace Holdings
Oct 23, 2024
Maintains: Buy
Price Target: $413 → $372
Current: $317.33
Upside: +17.23%
Veeva Systems
Aug 29, 2024
Maintains: Hold
Price Target: $180 → $192
Current: $212.03
Upside: -9.45%
Fortrea Holdings
Aug 13, 2024
Maintains: Hold
Price Target: $27 → $23
Current: $16.99
Upside: +35.37%
Charles River Laboratories International
Aug 12, 2024
Maintains: Hold
Price Target: $228 → $203
Current: $183.08
Upside: +10.88%
R1 RCM
Aug 5, 2024
Downgrades: Hold
Price Target: $20 → $14
Current: $14.26
Upside: +0.28%
GoodRx Holdings
May 16, 2024
Maintains: Buy
Price Target: $14 → $16
Current: $6.09
Upside: +162.68%
Cardinal Health
Aug 16, 2023
Maintains: Market Perform
Price Target: $88 → $90
Current: $113.35
Upside: -20.60%
Talkspace
May 3, 2023
Maintains: Outperform
Price Target: $4 → $5
Current: $3.05
Upside: +64.20%
Mar 23, 2023
Downgrades: Market Perform
Price Target: $100 → $50
Current: $9.21
Upside: +442.65%
Dec 6, 2022
Initiates: Outperform
Price Target: $251
Current: $207.35
Upside: +21.05%
Oct 20, 2022
Maintains: Outperform
Price Target: $70 → $56
Current: $5.37
Upside: +943.02%
Aug 16, 2022
Maintains: Outperform
Price Target: $18 → $14
Current: $0.93
Upside: +1,408.13%
Jun 21, 2022
Maintains: Outperform
Price Target: $48 → $50
Current: $23.98
Upside: +108.51%
Apr 18, 2022
Maintains: Outperform
Price Target: $325 → $361
Current: $524.67
Upside: -31.19%
Jul 16, 2020
Initiates: Outperform
Price Target: $3,240
Current: $1.79
Upside: +181,412.61%
Feb 13, 2018
Initiates: Market Perform
Price Target: $35
Current: $20.01
Upside: +74.96%